PedAM
Pediatric Disease Annotations & Medicines
| Disease | malnutrition |
| Phenotype | C0023890|liver cirrhosis |
| Sentences | 13 |
| PubMedID- 20576106 | Causes for malnutrition in liver cirrhosis are known to include a reduction in oral intake (for various causes), increased protein catabolism and insufficient synthesis, and malabsorption/maldigestion associated with portal hypertension [3,5,6]. |
| PubMedID- 20618455 | Aim: a late evening snack (les) is recommended for protein-energy malnutrition in patients with liver cirrhosis. |
| PubMedID- 26036456 | The patient had a past history of liver cirrhosis hcv-related with a severe malnutrition, hypertrophic cardiomyopathy, diverticular disease, hiatal ernia, previous appendectomy. |
| PubMedID- 23936183 | Bcaa has been used as a supplemental therapy to improve malnutrition in patients with liver cirrhosis [1]. |
| PubMedID- 24829672 | malnutrition in liver cirrhosis:the influence of protein and sodium. |
| PubMedID- 23027617 | Branched-chain amino acids (bcaa), which improve protein malnutrition in patients with liver cirrhosis, reduce the risk of hepatocellular carcinoma in these patients with obesity. |
| PubMedID- 23601060 | Free fatty acid as a marker of energy malnutrition in liver cirrhosis. |
| PubMedID- 20712878 | Bia has been used for the assessment of malnutrition in patients with liver cirrhosis. |
| PubMedID- 21518402 | Conclusion: les with bcaa-enriched nutrient therapy can improve protein malnutrition in patients with liver cirrhosis, and is more useful in the early stages of liver cirrhosis in improving hepatic parenchymal cell mass. |
| PubMedID- 21422706 | Energy malnutrition worsens survival in patients with liver cirrhosis, and is currently defined as non-protein respiratory quotient (nprq) <0.85, as measured by indirect calorimetry. |
| PubMedID- 22969221 | The effect of malnutrition on survival in patients with decompensated liver cirrhosis has not been well defined. |
| PubMedID- 25789501 | We found that supplementation with branched-chain amino acids (bcaa), which improve protein malnutrition in patients with liver cirrhosis [38], significantly inhibited liver carcinogen diethylnitrosamine (den)-induced hepatocarcinogenesis as well as spontaneously occurring hepatic preneoplastic lesions in db/db obese and diabetic mice [34,39]. |
| PubMedID- 24273224 | Supplementation with branched-chain amino acids (bcaa), which are used to improve protein malnutrition in patients with liver cirrhosis, can also reduce the risk of hcc in obese cirrhotic patients. |
Page: 1